Literature DB >> 23673542

Chondrosarcoma: A Diagnostic Imager's Guide to Decision Making and Patient Management.

Chika I Logie1, Eric A Walker, Jonathan A Forsberg, Benjamin K Potter, Mark D Murphey.   

Abstract

Chondrosarcoma is the third most common primary malignant bone tumor. Currently, outcomes are based largely on a histologic grading scale described by the World Health Organization (WHO) Classification of Bone Tumors (2002). This classification scheme possesses evident utility in the evaluation and management of higher grade tumors, but it is often unable to distinguish enchondromas from low-grade chondrosarcomas. This is problematic when low-grade lesions that are histologically similar to enchondromas demonstrate aggressive imaging features. Because histologic classification alone often belies the clinical significance of chondroid lesions, it is also important to consider radiologic staging as part of the clinical decision making process. This article focuses on medical decision support considerations relevant when confronted with this challenging subset of chondroid tumors, particularly differentiating the benign enchondroma from its notorious relative, the low-grade chondrosarcoma. In doing so, we present a review of the salient imaging features and discuss key differentiating characteristics. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23673542     DOI: 10.1055/s-0033-1342967

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  6 in total

Review 1.  F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.

Authors:  Ty K Subhawong; Aaron Winn; Shai S Shemesh; Juan Pretell-Mazzini
Journal:  Skeletal Radiol       Date:  2017-06-12       Impact factor: 2.199

2.  What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?

Authors:  Hassan Douis; M Parry; S Vaiyapuri; A M Davies
Journal:  Eur Radiol       Date:  2017-07-10       Impact factor: 5.315

3.  Exploring the key genes and pathways in enchondromas using a gene expression microarray.

Authors:  Zhongju Shi; Hengxing Zhou; Bin Pan; Lu Lu; Yi Kang; Lu Liu; Zhijian Wei; Shiqing Feng
Journal:  Oncotarget       Date:  2017-07-04

4.  Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma.

Authors:  Woo Hee Choi; Eun Ji Han; Ki Bong Chang; Min Wook Joo
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

5.  Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review.

Authors:  Claudia Deckers; Maarten J Steyvers; Gerjon Hannink; H W Bart Schreuder; Jacky W J de Rooy; Ingrid C M Van Der Geest
Journal:  Acta Orthop       Date:  2020-05-20       Impact factor: 3.717

6.  BL-038, a Benzofuran Derivative, Induces Cell Apoptosis in Human Chondrosarcoma Cells through Reactive Oxygen Species/Mitochondrial Dysfunction and the Caspases Dependent Pathway.

Authors:  Ju-Fang Liu; Chien-Yu Chen; Hsien-Te Chen; Chih-Shiang Chang; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.